Articles By Marcus Johnson

  1. Tekmira Awarded $140 Million Contract For Ebola Treatment Research 4/10/2014

    The U.S. Department of Defense has awarded Tekmira a $140 million contract to research a treatment for the Ebola virus.

  2. Northwestern, University Of Rochester Receive Funds To Research Parkinson's Disease Treatments 4/10/2014

    Northwestern University and University of Rochester were awarded a $23 million grant to conduct research on Parkinson's disease.

  3. India's Open Source Drug Discovery Program Faces Lack Of Funding 4/7/2014

    India's Open Source Drug Discovery Program, or OSDD, ran out of funding last week, as the ministry of science and technology did not clear the cabinet note to extend the project's funding on time. OSDD was created in 2008 in an effort to develop new drugs to treat neglected diseases, including Tuberculosis, Malaria, and Leishmaniasis.

  4. Biogen Idec And Whitehead Institute Collaborate For Drug Research Project 4/4/2014

    The Whitehead Institute is partnering with biotechnology firm Biogen Idec. In this arrangement, Biogen will provide $5.2 million to Whitehead Institute to fund up to five different research projects in the fields of neurology, immunology, developmental biology, and genetics.

  5. Ketamine Could Potentially Treat Patients With Severe Depression 4/4/2014

    Ketamine has potential to be used as a treatment for patients with severe depression, British researchers say.

  6. Researchers Use 3D Computer Technology To Create New Blood Cancer Drug 4/3/2014

    The St. Vincent's Institute of Medical Research in Australia is working to develop new blood cancer drugs to combat leukemia in the country.

  7. Researchers Uncover New Knowledge About Astrocytes' Role In Huntington's Disease 4/2/2014

    Researchers at the UCLA Brain Research Institute are working on discovering new ways to prolong survival for those affected by Huntington's disease

  8. Study Discovers Why MS Drug Tysabri Increases Risk Of PML 4/2/2014

    Researchers at the US National Institute of Neurological Disorders and Stroke (NINDS) believe that patients taking the MS drug Tysabri face a higher risk of developing the brain disease multifocal leukoencephalopathy (PML).

  9. Research Highlights Potential Drug Target For Mitochondrial Diseases 4/2/2014

    Researchers at the Whitehead Institute and Massachusetts Institute of Technology are working on developing new treatments for mitochondrial diseases.

  10. New Drugs Aim To Treat Ebola 3/28/2014

    Researchers are working on developing new drugs that could treat the Ebola virus. In January, Tekmira Pharmaceuticals began a human trial for an experiment treatment.